To participate and receive payment for vaccine administration, pharmacies must:

• Complete a Service Level Agreement (SLA)
• Order all program vaccine stock through Onelink

Both PBS and non-PBS pharmacies may participate.

The Pharmacy Guild of Australia WA Branch (PGAWA) will manage the remuneration process for all participating community pharmacies.

Pharmacies will be remunerated to a nominated bank account in two payment rounds per month for the duration of the Program.

Influenza Vaccination

The CPIPP supports pharmacist to administer influenza vaccines to the following eligible cohorts:

• NIP-funded influenza vaccine for children aged 2 to 4 years (as NIPVIP doesn't cover children under 5 years).
• State-funded influenza nasal spray vaccine for children aged 2 to 11 years  (FluMist®), as part of the 2026 WA Influenza Nasal Spray Vaccine Program.
• State-funded influenza vaccine for children aged 5 to 11 years (Fluzone®), under the WA Primary School Aged Influenza Program.
• State-funded influenza vaccine for persons aged 12 to 64 years, including persons without a Medicare card, and internation and interstate visitors (Fluzone®), under the 2026 Free Influenza Program, from 1 May to 30 June.

RSV Vaccination

The CPIPP supports pharmacist to administer RSV vaccines to the following eligible cohort:

• State-funded RSV vaccine (Arexvy®) to vulnerable* persons aged 60 - 74 years.
• State-funded vaccine (Arexvy®) to vulnerable * persons aged 50-59 years who have Medical Risk Conditions associated with increased risk of severe RSV disease.
• State-funded vaccine (Arexvy®) to vulnerable * persons aged 50-59 years who are Aboriginal and Torres Strait Islander (ATSI).

* Vulnerable persons include the following:

• Living in a residential aged care home.
• Receiving Commonwealth Support at Home **.
• Living in Specialist Disability Accommodation (SDA)***.
• In residential mental health services.
• Experiencing homelessness.
• In a correctional facility.

** Excludes persons on Support at Home waitlist and those on Commonwealth Home Support Package (CHSP)

*** Excludes Persons on SDA waitlist or receiving supported independent living (SIL)

RSV Decision Aid is available through the Department of Health, Western Australia.

Eligibility for a free RSV Arexvy® vaccine is outlined on the WA Department of Health webpage: WA RSV Immunisation Programs

The vaccines administered under the CPIPP have variable start and end dates as detailed in below table.

Private vaccine stock must NOT be used under the CPIPP

• All vaccines must be ordered via Onelink using the pharmacy's vaccine ordering account.
• Only vaccine brands listed in Onelink for each eligible cohort group should be used.
• Stock transfers between pharmacies are not permitted.

Further information on ordering vaccines can be found here.

For Onelink account or vaccine ordering enquiries, contact: vaccineorders@health.wa.gov.au.

• Vaccines may be administered in the pharmacy or at another compliant location within Western Australia, in line with the WA Department of Health SASA – Administration of Vaccines by Pharmacists - Appendix 2
• Pharmacies cannot claim payment from the PGAWA for privately purchased vaccines, or a vaccine funded by another program, such as private health fund vouchers or corporate vaccination services. Additionally, charging additional co-payments for vaccinations administered under this program is not acceptable.
• Pharmacies must ensure all influenza vaccines administered are recorded in the Australian Immunisation Register.

A payment of $20.05 (excl GST) will be made for administration of each vaccine administered under the CPIPP.

Pharmacies will be paid by PGAWA on behalf of the Western Australian Department of Health into their nominated bank account.

Payments will be made on receipt of vaccine data reports submitted via an email link which will be sent to pharmacies on the last day of each reporting period.

Report 1:

• Submissions for FluMist® vaccines administered between 1^st April and 14^th May open 15^th May 2026
• Submissions for the influenza and RSV vaccines administered between 1st May and 14th May 2026 open 15^th May 2026.

Submissions close on 22^nd May 2026.

Report 2:

• Submissions for FluMist®, influenza and RSV vaccines administered between 15th May and 31^st May 2026 open 2^nd June 2026.

Submissions close on 8^th June 2026.

Report 3:

• Submissions for FluMist®, influenza and RSV vaccines administered between 1st June and 15th June 2026 open 16^th June 2026.

Submissions close on 23^rd June 2026.

Report 4:

• Submissions for FluMist, influenza and RSV vaccines administered between 16^th June and 30^th June 2026 open 1^st July 2026.

Submissions close on 8^th July 2026.

If incorrect data is submitted, pharmacies should immediately email the corrected details to cpipp@wa.guild.org.au.

The Australian Immunisation Register (AIR) is a national immunisation register that records vaccines given to all people in Australia. This includes COVID-19 vaccines, vaccines given under the National Immunisation Program (NIP), and vaccines given privately, such as for seasonal influenza or travel.

Under the Australian Immunisation Register Act 2015, it is mandatory for all vaccination providers to report the administration of COVID-19, influenza, NIP and Japanese encephalitis virus (JEV) vaccines to the AIR.

AIR reports can be generated through your professional services software (e.g. MedAdvisor, Go-Bookings) or via the Australian Immunisation Register (AIR) portal.

Information on recording vaccinations in AIR can be found on Manage immunisation records in AIR - Health professionals - Services Australia.

If incorrect data is submitted to the AIR, please amend these records on the AIR.

Pharmacies can find further information on making amendments using the AIR site or with practice management software here, and updating vaccination data already submitted to the AIR site here. Pharmacies should also immediately email the corrected details to cpipp@wa.guild.org.au.

The Western Australian Government reserves the right to audit participating pharmacies and order them to repay or take other action if they determine it is appropriate.